| Ticker Symbol | Name | Issuer | Category | Market Cap | Yield | Expense Ratio | Last Price | 30 Day Change % | Description |
|---|---|---|---|---|---|---|---|---|---|
| PPH | VanEck Pharmaceutical ETF | VanEck | Passive Equity | $495,607,464 | 1.79% | 0.36% | $82.13 | -3.37% | VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR). |
| PILL | Direxion Daily Pharmaceutical & Medical Bull 3X Shares | Direxion | Passive Equity | $12,577,506 | 2.30% | 0.97% | $9.28 | -21.53% | Seek daily investment results, before fees and expenses, of 300% of the performance of the S&P Pharmaceuticals Select Industry Index. There is no guarantee the fund will meet its stated investment objective. |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | First Trust | Fixed Income | $19,578,652 | 1.45% | 0.60% | $26.92 | -6.80% | Seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index™. |
| IHE | iShares U.S. Pharmaceuticals ETF | Blackrock | Passive Equity | $650,148,000 | 1.41% | 0.39% | $189.89 | -6.12% | Seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. |
| XPH | SPDR S&P Pharmaceuticals ETF | State Street Global X Advisors | Passive Equity | $193,903,000 | 1.46% | 0.35% | $43.26 | -7.30% | Seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the “Index”) |
| PJP | Invesco Dynamic Pharmaceuticals ETF | Invesco | Passive Equity | $266,973,240 | 0.94% | 0.58% | $77.81 | -3.18% | The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index |
| KURE | KraneShares MSCI All China Health Care Index ETF | CICC | Active Equity | $47,602,560 | 0.76% | 0.65% | $17.25 | 2.38% | KURE tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. |
| CHIH | Global X MSCI China Health Care ETF | Global X | Active Equity | $7,431,025 | 0.59% | 0.65% | $13.48 | 1.03% | CHIH tracks a market cap-weighted index of Chinese large- and mid-cap companies in the health care sector. The index includes A shares. |
| CHB | Global X China Biotech Innovati | Global X | Passive Equity | $0 | 0.00% | 0.67% | $7.14 | 0.00% | Seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index. |
| CHNA | Loncar China BioPharma ETF | Exchange Traded Concepts | Passive Equity | $0 | 0.00% | 0.79% | $14.84 | 0.00% | The China BioPharma ETF offers exposure to a basket of companies powering China's biopharmaceutical industry. With a long-term goal of steering its economy towards innovation, China aims be a global leader in medicine. |
| POTX | Global X Cannabis ETF | Mirae Asset Global Investments Co., Ltd. | Active Equity | $0 | 0.00% | 0.51% | $6.41 | 0.00% | Seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cannabis Index. |